By Karen Peattie Dxcover has appointed diagnostics industry professional Dr David Eustace as operations director to drive product development, manufacturing, regulatory and laboratory operations. The appointment comes following a period of substantial growth for the Strathclyde University spinout, which is developing blood tests for early detection of cancer. Dr Eustace joins the team from Bruker Daltonics, the American-owned scientific instruments and diagnostics company, where he worked as operations director in Germany and Scotland. He has more than 13 years’ experience in the industry, working for Renishaw Diagnostics and Bruker Molecular Testing, most recently on its Covid-19 response projects at its plant in Germany.